Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment

被引:4
作者
Awisat, Abid [1 ]
Keret, Shiri [1 ]
Silawy, Amal [2 ]
Kaly, Lisa [1 ]
Rosner, Itzhak [1 ]
Rozenbaum, Michael [1 ]
Boulman, Nina [1 ]
Shouval, Aniela [1 ]
Rimar, Doron [1 ]
Slobodin, Gleb [1 ]
机构
[1] Bnai Zion Med Ctr, Rheumatol Unit, Haifa, Israel
[2] Maccabi Hlth Serv, Rheumatol Clin, Haifa, Israel
关键词
Diagnosis; giant cell arteritis; monitoring; treatment; COLOR-DUPLEX ULTRASONOGRAPHY; LARGE-VESSEL INVOLVEMENT; POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS; AMERICAN-COLLEGE; VISUAL-LOSS; FOLLOW-UP; BIOPSY; ULTRASOUND; PREVALENCE;
D O I
10.5041/RMMJ.10496
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) is the most prevalent subtype of vasculitis in adults. In recent years, there has been substantial improvement in the diagnosis and treatment of GCA, mainly attributed to the introduction of highly sensitive diagnostic tools, incorporation of modern imaging modalities for diagnosis and monitoring of large-vessel vasculitis, and introduction of highly effective novel biological therapies that have revolutionized the field of GCA. This article reviews state-of-the-art approaches for the diagnosis, monitoring, and treatment options of GCA.
引用
收藏
页数:11
相关论文
共 88 条
[1]   Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series [J].
Adizie, T. ;
Christidis, D. ;
Dharmapaliah, C. ;
Borg, F. ;
Dasgupta, B. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (09) :906-909
[2]   Relapses in Patients With Giant Cell Arteritis Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients [J].
Alba, Marco A. ;
Garcia-Martinez, Ana ;
Prieto-Gonzalez, Sergio ;
Tavera-Bahillo, Itziar ;
Corbera-Bellalta, Marc ;
Planas-Rigol, Ester ;
Espigol-Frigole, Georgina ;
Butjosa, Montserrat ;
Hernandez-Rodriguez, Jose ;
Cid, Maria C. .
MEDICINE, 2014, 93 (05) :194-201
[3]   Clinical importance of the presence of giant cells in temporal arteritis [J].
Armstrong, A. T. ;
Tyler, W. B. ;
Wood, G. C. ;
Harrington, T. M. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (05) :669-671
[4]  
BENGTSSON BA, 1981, ACTA MED SCAND, V209, P337
[5]   Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) [J].
Bienvenu, B. ;
Ly, K. H. ;
Lambert, M. ;
Agard, C. ;
Andre, M. ;
Benhamou, Y. ;
Bonnotte, B. ;
de Boysson, H. ;
Espitia, O. ;
Fau, G. ;
Fauchais, A. -L. ;
Galateau-Salle, F. ;
Haroche, J. ;
Heron, E. ;
Lapebie, F. -X. ;
Liozon, E. ;
Nguyen, L. B. Luong ;
Magnant, J. ;
Manrique, A. ;
Matt, M. ;
de Menthon, M. ;
Mouthon, L. ;
Puechal, X. ;
Pugnet, G. ;
Quemeneur, T. ;
Regent, A. ;
Saadoun, D. ;
Samson, M. ;
Sene, D. ;
Smets, P. ;
Yelnik, C. ;
Sailler, L. ;
Mahr, A. .
REVUE DE MEDECINE INTERNE, 2016, 37 (03) :154-165
[6]   Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis [J].
Bley, T. A. ;
Reinhard, M. ;
Hauenstein, C. ;
Markl, M. ;
Warnatz, K. ;
Hetzel, A. ;
Uhl, M. ;
Vaith, P. ;
Langer, M. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (08) :2574-2578
[7]   Aortic involvement in giant cell arteritis: Current data [J].
Bossert, Marie ;
Prati, Clement ;
Balblanc, Jean-Charles ;
Lohse, Anne ;
Wendling, Daniel .
JOINT BONE SPINE, 2011, 78 (03) :246-251
[8]   Place of azathioprine in the treatment of giant cell arteritis [J].
Boureau, A. -S. ;
de Faucal, P. ;
Espitia, O. ;
De Decker, L. ;
Agard, C. .
REVUE DE MEDECINE INTERNE, 2016, 37 (11) :723-729
[9]   Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis [J].
Boyev, LR ;
Miller, NR ;
Green, WR .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (02) :211-215
[10]  
Calderón-Goercke M, 2020, CLIN EXP RHEUMATOL, V38, pS112